| Saira Morales Gonzalez, SLP | |
|
42098 Sect Piquinas, Quebradillas, PR 00678-9492 | |
| (939) 645-5081 | |
| Not Available |
| Full Name | Saira Morales Gonzalez |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 42098 Sect Piquinas, Quebradillas, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124889464 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 4548 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Saira Morales Gonzalez, SLP 42098 Sect Piquinas, Quebradillas, PR 00678-9492 Ph: (939) 645-5081 | Saira Morales Gonzalez, SLP 42098 Sect Piquinas, Quebradillas, PR 00678-9492 Ph: (939) 645-5081 |
News Archive
The National Institutes of Health has awarded Clemson University professor Maria Mayorga and Medical University of South Carolina professor Kelly Hunt a $735,000 grant to study the effects of a mother's obesity and diabetes on infant health in certain ethnic groups.
Researchers at UC Davis, Genentech and Foundation Medicine are the first to show that a blood-based test to assess tumor mutational burden accurately identifies non-small cell lung cancer (NSCLC) patients who could benefit from immunotherapies called checkpoint inhibitors.
ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR Biosciences Holdings, Inc. (OTCBB: IRBS), today announced that its lead anti-influenza drug, Homspera, will be tested for efficacy against highly lethal H5N1 Avian Influenza in the laboratories of a widely respected University scientist. Additionally, testing at an independent facility will further define the adjuvant efficacy of Homspera when coupled with a novel vaccine for H5N1 in studies sponsored by an ImmuneRegen industry partner.
The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, which will be conducted by the ACTG.
New guidelines, released by the Centers for Disease Control and Prevention and the Healthcare Infection Control Practices Advisory Committee outline steps to eliminate bloodstream infections in patients with intravenous catheters, which are among the most deadly and costly healthcare-associated infections.
› Verified 7 days ago
Ms. Awilda Rosa-morales, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Hc-02 Box 8298, Quebradillas, PR 00678 Phone: 787-466-1967 Fax: 787-830-1654 | |
Miss Keyla Mabel Barreto, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Carreterra 113 Ramal 478 K1 H0, Bo.san Antonio, Quebradillas, PR 00678 Phone: 787-356-2841 | |
Mrs. Zaida J Garcia Dejesus, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Carretera 484 Km 1.0, Barrio Cocos, Quebradillas, PR 00678 Phone: 787-669-4081 Fax: 787-895-3465 | |
Catherine Cadiz, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Hc-03 Box 18089, Quebradillas, PR 00678 Phone: 787-361-3030 |